Sign in
Taking people in United StatesNo phase

Nerve block injection for postural tachycardia syndrome compared with a saline sham injection

Tests a stellate ganglion block against a sham injection in adults with postural tachycardia syndrome.

Key facts

Who runs it
Stanford University
Where
Stanford, United StatesSee the 2 sites
Trial code
Registry title
Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
Status
Recruiting
People taking part
20 people, planned
Started
16 Oct 2025
Expected to end
May 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Stellate ganglion block
  • Sham injection of saline
  • Ropivacaine
  • Normal saline
Record updated
28 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults diagnosed with POTS (Postural Tachycardia Syndrome, a fast heartbeat on standing up). It tests a nerve block in the neck against a fake (sham) injection.

Age
>18 years
Sex
All sexes can join.
Disease stage
A diagnosis of POTS.

Main reasons for not taking part

  • Allergy to local anesthetics (numbing drugs).
  • Severe problems with blood clotting.
  • Past or current significant heart rhythm problems, heart failure or myocarditis (heart inflammation).
  • Pulmonary embolism (lung blood clot) needing blood thinners, pulmonary fibrosis or other lung problems that may cause POTS symptoms.
  • Not able to keep medicines stable during the study.

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adult patients (>18 years of age) diagnosed with POTS
  • Ability to provide informed consent
  • Ability to comply with 3 follow up visits
  • English speaking and capable of signing informed consent and complying with protocol requirements

Who cannot take part

  • Inability to maintain a stable medication regiment for the duration of the study
  • Allergy to local anesthetics
  • History of or currently being treated for clinically significant ongoing cardiac arrhythmia, heart failure, myocarditis, pulmonary embolism requiring anticoagulation, pulmonary fibrosis or other pulmonary diagnosis that in the investigator's opinion may contribute to symptoms of POTS
  • Severe coagulopathy

Where in United States

  • Stanford UniversityStanford, United StatesContact: Anna Maria Bombardieri, MDTaking people
  • Stanford University School of MedicineStanford, United StatesContact: Anna Maria Bombardieri, MD, PhDTaking people

About the trial

What the trial wants to find out

This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.

The 2 groups in the trial

  • Intervention Group (stellate ganglion block)Treatment being tested

    Patients will receive an ultrasound guided stellate ganglion block (SGB) with 10 ml of 0.5% ropivacaine.

    Treatment: Stellate ganglion block and Ropivacaine

  • Control Group (sham injection with saline)Sham treatment, for comparison

    Patients will receive a subcutaneous sham injection with saline. Ultrasound imaging will be used to simulate the guidance process as in the active procedure, maintaining consistency in the procedural experience.

    Treatment: Sham injection of saline and Normal saline

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome: A Randomized Double Blind Sham Placebo-controlled Pilot Study
Plain-language title
Nerve block injection for postural tachycardia syndrome compared with a saline sham injectionGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
28 October 2026